Novadip Biosciences: Clinical Trials

7 trials sponsored by Novadip Biosciences, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 2 completed, 2 recruiting, 1 unknown. 6 Phase 1, 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 16Active not recruiting 2, Completed 2, Recruiting 1, Unknown 1
Phase 25Active not recruiting 2, Completed 2, Recruiting 1
Phase 31Recruiting 1

Follow Novadip Biosciences: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.
NVD003, Iliac Crest Bone Graft - Congenital Pseudarthrosis of Tibia
Phase 3RecruitingNovadip Biosciences122025-09-022026-04-01
Long-term Safety Trial with NVDX3
NVDX3 - Distal Radius Fractures, Degenerative Lumbar Spondylolisthesis
Phase 1 / Phase 2RecruitingNovadip Biosciences152024-08-222024-09-05
Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis
NVDX3 - Degenerative Lumbar Spondylolisthesis
Phase 1 / Phase 2Active not recruitingNovadip Biosciences52023-10-122025-12-24
Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures.
NVDX3 - Distal Radius Fractures
Phase 1 / Phase 2CompletedNovadip Biosciences112023-08-082026-01-28
NVD-003 in the Treatment of Congenital Pseudarthrosis of the Tibia
NVD-003, an autologous 3D scaffold free osteogenic graft - Congenital Pseudarthrosis of Tibia
Phase 1UnknownNovadip Biosciences42022-11-242024-01-26
Prospective Study in Adults Evaluating Safety & Efficacy of NVD003 for Bone Reconstruction to Treat Lower Limb Nonunion
NVD003 - Recalcitrant Lower Limb Nonunion
Phase 1 / Phase 2Active not recruitingNovadip Biosciences112018-08-022024-03-28
Safety and Preliminary Effectiveness of NVD-001 for the Treatment of Low Grade Degenerative Lumbar Spondylolisthesis
NVD-001, Standard of Care - Spondylolisthesis
Phase 1 / Phase 2CompletedNovadip Biosciences482017-01-012021-08-13

Conditions studied

Pseudarthrosis (2)  ·  Wrist Fractures (2)  ·  Spondylolisthesis (1)

Interventions

Standard of Care (1)

Countries

Belgium (4)  ·  Luxembourg (4)  ·  United States (2)  ·  Czechia (1)  ·  France (1)  ·  Poland (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Torsten Gerich, MD (2)  ·  Christian Raftopoulos, MD, PhD (1)  ·  Christophe Marchal, MD (1)  ·  Denis Dufrane, MD, PhD (1)  ·  Philip McClure, MD (1)  ·  Pierre-Louis Docquier (1)

NIH funding

2016 (1), 2023 (1), 2025 (1)